Massachusetts Financial Services
KDNY

Massachusetts Financial Services’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Massachusetts Financial Services’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-31,948
Closed -$2.05M – 882
2016
Q1 		$2.05M Buy
31,948
+402
+1% +$32.5K ﹤0.01% 703
2015
Q4 		$4.44M Buy
31,546
+17,292
+121% +$2.35M ﹤0.01% 665
2015
Q3 		$1.38M Sell
14,254
-9
-0.1% -$1.07K ﹤0.01% 745
2015
Q2 		$2.16M Buy
+14,263
New +$2.36M ﹤0.01% 746

Other funds holding KDNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Massachusetts Financial Services's KDNY Position: Q2 2016 in Review

Massachusetts Financial Services sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2016, closing a stake of 31,948 shares — an estimated $2.05M sold.

Massachusetts Financial Services first reported a position in KDNY in Q2 2015 and held it in 4 quarters. The position peaked at $4.44M in Q4 2015. 102 funds tracked by Wall St. Rank hold KDNY as of Q2 2016.

  • Massachusetts Financial Services reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Massachusetts Financial Services sold 31,948 Chinook Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $2.05M.
  • Massachusetts Financial Services first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 4 quarters.
  • Massachusetts Financial Services's Chinook Therapeutics, Inc. Common Stock position peaked at $4.44M in Q4 2015.
  • 102 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Massachusetts Financial Services's 13F filing for Q2 2016, filed 12 Aug 2016.